Adult, Adolescent and Children aged 6 years or older with primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatment ( eg exercise weight reduction) is inadequate. Adult, adolescents, and children aged 6 years old or older with homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatment ( LDL apheresis) or if such treatment are not appropriate. Prevention of Cardiovascular Events: Prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular event as an adjunct to correction of other risk factors.

This is not a substitute for consulting your doctor. Seek professional advice if you are experiencing any illness or symptoms.

Before treatment initiation the patient should be placed on a standard cholesterol-lowering diet that should continue during treatment. The dose should be individualized according to the goal of therapy and patient response, using current consensus guidelines.

Rosuvastatin may be given at any time a day, with or without food.